Article
Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008.
Pharmacoepidemiology and drug safety - 1 Mar 2010
Huang Wan-Ting, Chang Soju, Miller Elaine R, Woo Emily Jane, Hoffmaster Alex R, Gee Jay E, Clark Thomas A, Iskander John K, Ball Robert, Broder Karen R
Abstract excerpt
PURPOSE: On 13 December 2007, Merck & Co., Inc. voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines that had been distributed since April 2007 for concerns regarding potential Bacillus cereus contamination. Enhanced postrecall surveillance was conducted to detect vaccine-associated B. cereus infections. METHODS: We reviewed reports involving recalled Hib vaccines received by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
